FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 117 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 6.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,662,000 | +45.0% | 347,939 | +0.7% | 0.01% | +20.0% |
| Q4 2018 | $3,215,000 | -65.9% | 345,685 | -49.0% | 0.01% | -16.7% |
| Q3 2018 | $9,426,000 | +75.8% | 677,192 | +99.7% | 0.01% | -14.3% |
| Q2 2018 | $5,361,000 | +12.4% | 339,110 | +22.1% | 0.01% | +16.7% |
| Q1 2018 | $4,770,000 | -19.9% | 277,630 | +2.2% | 0.01% | -25.0% |
| Q4 2017 | $5,956,000 | -43.8% | 271,703 | +4.9% | 0.01% | -42.9% |
| Q3 2017 | $10,599,000 | +36.4% | 259,069 | +0.4% | 0.01% | +27.3% |
| Q2 2017 | $7,769,000 | -11.0% | 258,011 | +6.9% | 0.01% | -15.4% |
| Q1 2017 | $8,726,000 | -27.0% | 241,371 | +1.2% | 0.01% | -31.6% |
| Q4 2016 | $11,948,000 | -3.9% | 238,428 | +0.7% | 0.02% | -9.5% |
| Q3 2016 | $12,433,000 | +29.1% | 236,870 | +1.7% | 0.02% | +23.5% |
| Q2 2016 | $9,629,000 | +26.1% | 232,862 | +23.9% | 0.02% | +21.4% |
| Q1 2016 | $7,637,000 | +16.8% | 187,969 | +19.3% | 0.01% | +16.7% |
| Q4 2015 | $6,539,000 | +175.4% | 157,566 | +2.2% | 0.01% | +140.0% |
| Q3 2015 | $2,374,000 | -38.0% | 154,237 | 0.0% | 0.01% | -28.6% |
| Q2 2015 | $3,831,000 | +511.0% | 154,237 | +461.8% | 0.01% | +600.0% |
| Q1 2015 | $627,000 | -3.2% | 27,455 | +14.5% | 0.00% | 0.0% |
| Q4 2014 | $648,000 | +130.6% | 23,987 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $281,000 | -24.7% | 23,987 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $373,000 | +29.5% | 23,987 | +63.6% | 0.00% | 0.0% |
| Q1 2014 | $288,000 | +209.7% | 14,660 | +164.1% | 0.00% | – |
| Q4 2013 | $93,000 | – | 5,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|